Life Science

Mon, 26/10/2020 - 07:30
    Sperm DNA fragmentation measured by the Exact® test is a novel biomarker for early pregnancy loss
Tue, 13/10/2020 - 12:30
Join the debate that determines MedTech’s future
Solentim VIPS
Wed, 07/10/2020 - 07:30
Bournemouth, UK, 7th October 2020 / Sciad Newswire / Solentim is pleased to announce the adoption of its 
Wed, 30/09/2020 - 07:30
NanoSyrinx is the first company to engineer ‘nanosyringes’, a selective non-viral peptide and protein delivery system identified in an undisclosed organism.
Mon, 28/09/2020 - 10:30
New opinion piece from Watson-Marlow Fluid Technology Group launched today
Wed, 23/09/2020 - 08:00
VIPS™ + MatriClone™ combination ensures high efficiency seeding of hiPSCs with high viability
Thu, 17/09/2020 - 15:19
Falmouth, UK, 17th September 2020 / Sciad Newswire / Single-use technology has been touted as the latest and most promising development in bioprocessing technolog
Thu, 17/09/2020 - 12:00
The Huntington Study Group (“HSG”), a world leader in clinical research for Huntington’s Disease (HD), announces a partnership with Prilenia Therapeutics, a clinical stage biotech company led by Michael R. Hayden, MD, PhD, to conduct PRidopidine Outcome On Function in Huntington’s Disease (PROOF-HD) clinical study. PROOF-HD is a global Phase 3, randomized, double-blind, placebo-controlled, parallel arm, multicenter study evaluating the efficacy and safety of pridopidine in patients with early stage HD.
Mon, 14/09/2020 - 13:00
London, UK, 14th September 2020 / Sciad Newswire / WEP Group Holdings Limited (WEP), a specialist CRO focused on delive
Mon, 14/09/2020 - 09:00
Cambridge, UK, 14th September 2020/ Sciad Newswire / Check4Cancer, the provider of early cancer detection and genetic

Pages